chrisvoncsefalvay/vaers-outcomes huggingface dataset:
encephalitis; This is a spontaneous report received from a contactable reporter (Consumer) from medical information team, Program ID: (Unknown). The reporter is the parent.  A 14-year-old male patient received BNT162b2 (COMIRNATY), on 18Mar2022 as dose 3 (booster), single (Lot number: FK9729) at the age of 14 years, in left deltoid (reported as left shoulder) for covid-19 immunisation. The patient's relevant medical history included: "Cold" (unspecified if ongoing); "flus" (unspecified if ongoing). The patient was prior a healthy kid, has never been sick and was never in the hospital except for her giving birth to him. He had the cold and flus like every other kid. He was lean and not overweight and no medical history whatsoever (as reported). He is a server and an avid swimmer, on the swim team and a surfer; the specialists can't tell what cause it. There were no concomitant medications. Vaccination history included: BNT162b2 (DOSE 1, Lot: EW0196, Anatomical Location: Left upper arm shoulder), administration date: 09Jul2021, when the patient was 13-year-old, for COVID-19 immunization; BNT162b2 (DOSE 2, Lot: FA7485, Anatomical location: Left upper shoulder), administration date: 09Aug2021, when the patient was 13-year-old, for COVID-19 Immunization. The following information was reported: ENCEPHALITIS (hospitalization) with onset 25May2022, outcome "recovering". The patient was hospitalized for encephalitis (start date: 24May2022, discharge date: Jun2022). Also reported that he was at the hospital from 25May2022 to 16Jun2022 or 17Jun2022. After his booster he was hospitalized with encephalitis. The patient got all three shots from Pfizer. The first two normal vaccinations and then he was vaccinated with the bivalent (as reported) booster dose maybe a month (as reported) before he got encephalitis. The patient underwent the following laboratory tests and procedures: Chest X-ray: Unknown results; Electroencephalogram: Unknown results; Magnetic resonance imaging: Unknown results. Outcome was reported as improving. He does have the infection anymore (as reported) and he has a long road to recovery. Treatment indicated that the patient was in the ICU for two weeks and home for a week and a half and had to live in rebab for 2 weeks. Now, he was home, and he has so much therapy and he is supposed to be a freshmen in high school and only attends one class.
Second dose rash resembled red hives but not raised, warm and itchy.  Spread from injection site towards the elbow across the arm but not on the underside of the arm. Lasted a little over a week.
This case was reported by a consumer via call center representative and described the occurrence of nausea in a 79-year-old female patient who received SHINGRIX for prophylaxis. The patient's past medical history included shingles (very mild case of shingles on the back). Concurrent medical conditions included drug allergy (allergy to DEMEROL) and penicillin allergy. On 4th July 2018 10:30, the patient received the 1st dose of SHINGRIX (intramuscular). On 4th July 2018 18:00, 7 hrs 30 min after receiving SHINGRIX, the patient experienced nausea, diarrhea, headache, injection site erythema, injection site swelling, dehydration, shivering, fever, abdominal pain, swelling of eyelid, weakness, vomiting and muscle pain. The patient was treated with BENADRYL and TYLENOL. On 10th July 2018, the outcome of the swelling of eyelid was recovered/resolved. On an unknown date, the outcome of the nausea, diarrhea, headache, injection site erythema and weakness were recovering/resolving and the outcome of the injection site swelling, dehydration, shivering, fever, abdominal pain, vomiting and muscle pain were recovered/resolved. It was unknown if the reporter considered the nausea, diarrhea, headache, injection site erythema, injection site swelling, dehydration, shivering, fever, abdominal pain, swelling of eyelid, weakness, vomiting and muscle pain to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX on left arm. By 6:00 PM, the patient started to experience adverse reactions that were worse in the next morning. The patient experienced swelling on the top of her eyelids. The patient was dehydrated and went to the emergency room via the ambulance. The patient received fluids for rehydration and BENADRYL while in the emergency room. The patient was not admitted to the hospital. The patient had reported the event to her doctor and decided to not get the 2nd dose. The patient was taking TYLENOL for the headache. The patient provided contact details of the physician.
Vomiting- diarrhea-lethargic- sleepiness, fussy - from 18:15 pm 11/4/02 - till present (noon 11/5/05). Sticking tongue out, smacking lips, moving legs more slowly than previously.
very achy; have headaches today; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (very achy) and HEADACHE (have headaches today) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A and 025B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Apr-2021, the patient experienced MYALGIA (very achy) and HEADACHE (have headaches today). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of UNK dosage form. At the time of the report, MYALGIA (very achy) and HEADACHE (have headaches today) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the events was not Applicable.  Concomitant product use was not provided by the reporter. Treatment information included tylenol.
The symptoms began 10 minutes after administration of the vaccine.  The symptoms were: dizzy, lightheaded but BP elevated to 140s systolic, chest tightness, globus sensation with some difficulty swallowing but able to swallow zyrtec then head pain / headache that radiates down to neck. Given zyrtec. Not SOB and not wheezing, no rash or objective swelling of the face or oropharynx. The nurse reports that she cannot move her tongue very well.  The treatment of the reaction was:   o Antihistamines: zyrtec 10mg  o Sent patient to ED
fatigue; pain at injection site; swelling at the injection site; headache; This case was reported by a consumer via call center representative and described the occurrence of fatigue in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 26th July 2019, the patient received the 1st dose of Shingrix. In July 2019, 6 hrs after receiving Shingrix, the patient experienced fatigue, injection site pain, injection site swelling and headache. On an unknown date, the outcome of the fatigue, injection site pain, injection site swelling and headache were recovering/resolving.   It was unknown if the reporter considered the fatigue, injection site pain, injection site swelling and headache to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not reported. The patient received his 1st dose of Shingrix in the left arm. In the middle of the night, around 6-8 hours after receiving Shingrix, the patient experienced a reaction which included fatigue, swelling and pain at the injection site and a headache.  The patient claimed that his symptoms were improving but they were the worst on Saturday 27th July 2019. The reporter consented to follow up.
I have never had high blood pressure. Four days after the vaccine, my blood pressure rose to 225 /100. I went to the emergency room. They did an EKG, X-ray, blood tests and urine tests. They were all perfect. After 4 hours my blood pressure lowered tp 135 /90. However, every day for two weeks, my blood pressure rose in the middle of the day. Dr. put me on amlodiplepine (5mg). My blood pressure is now long again and I suspect Dr. will take me off the medicine next moth.
pt had an overnight admission to hospital for diagnosis COVID positive; dc'd to home and back to ED with worsening SOB & weakness, AHRF, AKI; O2 via NC, transitioned to Vapotherm, BiPAP; pt experienced A Fib and was treated; started on dexamethasone; pt's condition worsened and he was intubated; wife asked for extubation on 9/18/21 and pt was transitioned to comfort care; pt died in the hospital
This spontaneous report as received from a health professional refers to a patient of unknown age and gender. On 09-FEB-2015 the patient was vaccinated with a dose of ROTATEQ (dose and lot # not reported) that had undergone temperature excursions. No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose01/202/21 2nd dose02/10/21 Diagnosed covid positive:07/30/21 Symptom onset: Exposure:community Symptoms:cough, fatigue,muscle aches, loss of smell, sorethroat,chills,runny nose, HA
Prior to vaccine had a very mild and temporary case of tinnitus in left ear.  After vaccination it is more intense and is now continuous.
Left Shoulder pain. The pain was immediate after the individual slapped (not an exaggeration) the plunger, injecting the flu vaccine into the wrong muscle group. Since then I've had muscular pain in my left shoulder when raising my arm over my head, I'm also experiencing reduced flexibility in my left shoulder. I do not experience pain when my arm is at a resting position.
No adverse event; Dose-1 (20Feb2021) and Dose-2 (29Mar2021); This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose-1 (20Feb2021) and Dose-2 (29Mar2021)) and NO ADVERSE EVENT (No adverse event) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006B21A and 014M20A) for COVID-19 vaccination.     Concurrent medical conditions included Seizure and Blood pressure. Concomitant products included COLECALCIFEROL (VITAMIN D3) for an unknown indication.   On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose-1 (20Feb2021) and Dose-2 (29Mar2021)). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose-1 (20Feb2021) and Dose-2 (29Mar2021)) and NO ADVERSE EVENT (No adverse event) outcome was unknown.            Concomitant medications include unspecified seizure medication, unspecified blood pressure medication, unspecified water pill, and unspecified multivitamin for 50 plus.  No treatment information was provided.   This case was linked to MOD-2022-650836.
I started coughing a lot around 3:00p.m. After about thirty minutes of constant coughing I had trouble swallowing and I felt like something hard was stuck in my throat. I was drinking plenty of water not knowing what was causing the problem. Soon after I was getting dizzy and was having a difficult time breathing. My chest felt very tight and it was painful when I would take a deep breath. At this point I was weak and my eyes were red and swollen. I contacted my primary physician and I was told to take 25mg of Benadryl per mouth and to go to the nearest emergency room. I was unable to drive, my co-worker transported me to the hospital. When we arrived at hospital at approximately 4:15p.m. I was very weak, had a lot of chest pain, difficulty breathing and I had a difficult time walking due to the weakness I felt. I was immediately checked in the emergency room and they gave me a cortisone injection intramuscular. They had me under observation and took two radiographs of my chest. After several hours of observation I was released that same night. I was very tired and felt weak, still unable to drive myself home.
This spontaneous report was received a medical assistant and refers to a 16-month-old patient of unknown gender. The patient's pertinent medical history, concomitant medications and drug reactions or allergies were not reported. On 12-JUN-2017, the patient was 16 months old and was inadvertently administered one dose of GARDASIL 9 injection (lot # N001533 with expiration date at 16-OCT-2019; exact dose, route of administration and anatomical location were not reported), for prophylaxis. No adverse effects were reported. No product quality complaint (PQC) was involved. Additional information has been requested.
Patient reports she had chills and body aches several hours after receiving the PREVNAR 13 vaccine. The next day (6/5/18) she noticed redness at the injection site. The chills and body aches dissipated but she later developed a rash. No OTC medications were taken by the patient. Patient was seen again in our office on 6/2/2018. Her right arm was swollen and warm to touch with pruritic rash.
Severe Muscle pain in left leg. Had severe cramping like a Charlie horse and now it?s hard to walk. It?s in my thigh.
Pain, redness and warm to the touch injection site, Headache, jaw pain, generalized muscular and rib cage pain, Tired and sleepy. The day after injection per pt she took two doses of Tylenol and recuperated on the 2nd day after injection.
Site: Itching at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Systemic: Allergic: Itch (specify: facial area, extremeties)-Mild
This case was reported by a physician, via a sales representative, and described the occurrence of amenorrhea in a 14-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). On 19 December 2011 the subject received 1st dose of CERVARIX (details unknown). On 19 December 2011, less than one day after vaccination with CERVARIX, the subject experienced amenorrhea. The physician reported that the subject received her first dose of CERVARIX and had experienced amenorrhea since that time. The vaccination series was delayed. At the time of reporting the event was unresolved. The physician considered the event was possibly related to vaccination with CERVARIX. Follow-up information was received on 27 March 2012. It was reported that CERVARIX was administered intramuscularly in the left arm of the female subject on 19 December 2011. At that time, the subject was having menses. The subject experienced an absence of menses in January 2012 and February 2012. This resolved in March 2012 with the return of menses. In the reporter's opinion, the event was possibly related to vaccination with CERVARIX. No concurrent medications were noted. The subject returned for her 2nd dose of CERVARIX in March 2012. It was not known if the event recurred.
Presented w/ cough, SOB, hypoxia. Sx X 1 week. Tested Covid + at urgent care. Tx w/ Remdesivir, steroids, O2.
High fever 2-3 hrs p/vax higher than 103 & devel generalized seizures w/cyanosis; hospitalized;
Pt received Infanrix rather than ordered Adacel. M.D. called-no concern @ immunity coverage No exams reported
I have a diagnosed urinary tract infection a week after the first shot. I have a burning sensation and frequent urination. I was tested and confirmed a UTI by my doctor.
The first week itching and a hard lump, painful to touch Feb 25,2021 itching started again, larger lump reappeared, very warm to touch, 4 inch red circle
PATIENT REFERS HAVING A RASH ALL OVER THE BODY AND A RED EYE.
I have a question can the Pfizer covid injection enlarge your spleen have you had anyone with this reaction
Client experienced an episode of syncope immediately after receiving the vaccine.  Patient was put in Trendalenberg and administered ammonia inhalant.  Fire Rescue at scene to evaluate client.  Blood pressure very low during assessment although patient became a+ox3.  Client refused transport to ER as recommended by Fire Rescue.  Client transitioned to passenger seat and mother drove client home and was given instructions to call 911 if any symptoms of hypotension occurred.
had a bad headache; This is a spontaneous report received from a contactable consumer (consumer).  A 45-year-old male consumer received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on unknown date at single dose for COVID-19 immunisation. Medical history and concomitant medications were unknown. On unknown date, the patient experienced bad headache. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Hospitalization for COVID-19 & Diarrhea, admitted on 2/16  & still a patient on 2/20
Area shot received red, warm to touch, extremely swollen and extremely painful. Cannot lift arm more than halfway to shoulder. Worst vaccination ever received.
Dizziness, brain fog, sleep disturbances, loss of words, flushing, heart problems like POTS, swallowing issues, vision problems, etc. sick for 5 months.  Current treatment antihistamines. Feeling better, have appointment with specialist in November.
Resident received PCV13 05/26/2015. Resident should have received PPSV23 on 12/17/2018; a second PCV13 was given on 12/17/2018. No injury apparent.
Patient started to feel a little shaky initially on 12/30/20 around 12:00PM. She came into the clinic a few minutes later, about 12:45pm.  By the time we saw her she was experiencing rigors. She was treated in clinic with Acetaminophen 650mg. Her rigors stopped and she was sent home to rest. She was instructed to f/u on 12/31 if needed.
Cerebral infarction. Acute hydrocephalus. Cerebral edema. Stenosis of the lower cerebral artery.
Same day of injection: left arm and leg pain followed by left neck pain Following day: left supraclavicular lymphadenopathy incidentally noted
Day of vaccine: mild fatigue and increasing arm soreness  Day after vaccine: dizziness, nausea, vomiting 2 Days after vaccine: dizziness, nausea, vomiting
This initial spontaneous report was received from a registered nurse referring to an unspecified number of patients of unknown ages and genders. There was no pertinent medical history, concomitant medication or drug allergies/drug reactions described. On unknown dates, the patients were vaccinated with improperly stored doses of VARIVAX injection (lot # L024252 with expiration date 30-JUN-2017; dose and route were not provided). The product had a temperature excursion with temperature -3.7 degrees C for 16 hours (the door was open). VARIVAX was supported until expiry. There was no previous temperature excursion. No adverse effects were reported. It was unknown if the patients sought medical attention. Product quality complaint (PQC) was not involved. Additional information has been requested.
Marked local swelling, induration, erythema, warmth, and tenderness resulting in a physician office visit.
This spontaneous report as received from a physician refers to a patient of unknown age and gender. There were no concomitant medications, concurrent conditions and medical history reported. On 06-OCT-2015, the patient was inadvertently vaccinated with (Oka/Merck) VARIVAX lot# L013064, exp. 14-APR-2017 (route of administration and dose were not reported), that had been improperly stored. There was no adverse effects reported. Additional information is not expected as the reporter did not wish further contact.
11.14.08 redness, swelling @ injection site, Lt deltoid. (1) KEFLEX 500mg cap 1 tid. (2) Prednisone 20 mg tab 2 tab Qd x 5
Red, swollen, itchy, instructed mom to apply cool compress and give BENADRYL, amount according to dosing chart.
34 y/o AD male with hx of hospitalization s/p AVA #6 for pericarditis/pericardial effusion July 2004, concerned receiving further doses of AVA. PCP contacts agency-temporary exemption from AVA granted till case reviewed. Symptoms: Dyspnea (shortness of breath), fatigue, fever. 2/20/09 Received medical records of 2004. FINAL DX: acute CMV infection w/bilateral pleural effusions, fever, lymphadenopathy, splenomegaly, ascites, anasarca, pericardial effusion Records of t/c on 7/16/2004 reveal patient experienced aches, malaise, fatigue, fever, weakness, diet refusal, oral intake reduced, chills, joint & muscle aches, pallor.  Saw MD & dx w/probable viral syndrome.  Symptoms worsened & admitted to hosp 7/30/04-8/03/2004.  ID & cardio consults done.  Diuresised & improved. D/C to home w/ID & cardio f/u.  Repeat CT scan 9/04 revealed pleural & pericardial effusions resolved; free fluid in pelvis resolved; mildly improved splenomegaly; no change in lymphadenopathy.
Fever, chills, shaking started at 3 am and persisted even with tylenol until the next evening. Fever ranged from 99.5 to 102.5. Headache-severe and nausea lasted until  the following day,  muscle aches and weakness severe until two days later.  It?s now  4 days and still have significant weakness and persistent cough and chest  tightness and discomfort.
30 minutes after, ring finger and middle finger went numb. 2 hours later was unable to lift arm. that evening terrible pains, could not sleep, no function in arm for 3 days. the pains felt like I tore my rotator. I felt my shoulder was broke. still have issues now have moved into elbow and hand goes numb some. lifting is hard.
sterile abscess lt thigh sx first noted on 24MAR95 by mom; pt seen in clinic 27MAR95; mom reported bruise appear 2 days p/inj; site hard to touch & swollen; MD noted 3/4cm nodule lt thigh;
Severe headaches, pain in body, night sweats, weakness in legs, tiredness, lumps throughout body, ringing in ears, unbalanced when walking
TIRED; BODY ACHE; CHILLS; RAISED BODY TEMPERATURE; SORE ARM; This spontaneous report received from a patient concerned a 34 year old of unspecified sex. The patient's height, and weight were not reported. The patient's past medical history included pneumonia, and bronchitis. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry: UNKNOWN) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On MAR-2021, the subject experienced sore arm. Laboratory data included: Body temperature (NR: not provided) 101.6. On 20-MAR-2021, the subject experienced raised body temperature. On 20-MAR-2021 22:30, the subject experienced chills. On 21-MAR-2021 18:00, the subject experienced tired. On 21-MAR-2021 18:00, the subject experienced body ache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, raised body temperature, tired, and body ache on MAR-2021, and had not recovered from sore arm. This report was non-serious.
Not received 2nd dose yet; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 67-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in 2019).  On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: Not received 2nd dose yet). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 20-OCT-2023 The pharmacist reported that she had a patient who appeared to have had their first Shingrix in 2019, and he thought that he had received his 2nd dose however, not sure. The vaccine was not given in the reporter's facility and she did not had the exact date, lot number, or expiration date information. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter consented to follow up.